Conditions: Lung Cancer, Small Cell
Keywords: chemonaive small cell lung cancer untreated Lung cancer HYCAMTIN first-line extensive disease
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 33
Healthy volunteers: no

Brief summary:
This study was designed to find the safest and most effective dose of a combination of two chemotherapy drugs, Hycamtin® (topotecan) and Paraplatin® (carboplatin), in people with extensive disease small cell lung cancer.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: topotecan intervention 2: carboplatin
Intervention descriptions: intervention 1: Hycamtin and Carboplatin as first-line treatment of chemonaive subjects with EX-SCLC. intervention 2: Hycamtin and Carboplatin as first-line treatment of chemonaive subjects with EX-SCLC.

Protocol document: